Vegge, Andreas
Novo Nordisk (Denmark)
4 papers on CoChat
Most cited papers
- Verified
Transcellular Stomach Absorption of a Derivatized Glucagon-Like Peptide-1 Receptor Agonist
Buckley, S. T., Bækdal, T. A., Vegge, A., Maarbjerg, S. J., Pyke, C., Ahnfelt-Rønne, J., Madsen, K. G., Schéele, S. G., Alanentalo, T., Kirk, R. K., et al. (2018) · Science Translational Medicine
Drug Solubulity and Delivery SystemsAdvanced Drug Delivery Systems
Cited by 553
- Verified
Zwitterionically modified alginates mitigate cellular overgrowth for cell encapsulation
Liu, Q., Chiu, A., Wang, L.-H., An, D., Zhong, M., Smink, A. M., de Haan, B. J., de Vos, P., Keane, K., Vegge, A., et al. (2019) · Nature Communications
Tissue Engineering and Regenerative MedicinePancreatic function and diabetes
Cited by 202
- Verified
Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study
Dahl, K., Toubro, S., Dey, S., Duque do Vale, R., Flint, A., Gasiorek, A., Heydorn, A., Jastreboff, A. M., Key, C., Petersen, S. B., et al. (2025) · The Lancet
Pharmacology and Obesity TreatmentDiabetes Treatment and Management
Cited by 80
- Verified
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial
Gasiorek, A., Heydorn, A., Gabery, S., Hjerpsted, J. B., Kirkeby, K., Kruse, T., Petersen, S. B., Toubro, S., Vegge, A., & Key, C. (2025) · The Lancet
Pharmacology and Obesity TreatmentDiabetes Treatment and Management
Cited by 46
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free